Relay Therapeutics Cash Flow Statement (2019-2026) | RLAY

Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-61.92M-73.44M-80.07M-92.41M-85.28M-75.06M-100.57M-112.41M-74.27M-107.91M-82.71M-93.56M-88.39M-484.87M-77.97M-73.98M-74.22M-35.09M-79.13M-85.32M
Depreciation and Depletion (Quarter)
1.01M1.01M0.97M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M0.36M
Share-based Compensation (Quarter)
12.42M1.20M13.46M15.15M13.72M9.51M21.52M23.41M21.84M19.27M27.19M15.62M11.08M17.64M19.32M9.31M9.53M-42.44M10.54M5.84M
Gains from Investment Securities (Quarter)
0.84M-4.59M
Cash from Operations (Quarter)
-53.20M-39.71M-49.17M-57.09M-66.14M-57.08M-67.13M-68.60M-75.40M-89.19M-50.32M-65.83M-75.08M-57.87M-73.21M-55.26M-62.12M-44.87M-51.11M-54.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.67M-0.68M-0.68M-0.55M-0.34M0.39M2.02M2.20M2.88M3.67M3.67M3.29M3.18M2.18M1.60M1.39M1.10M0.86M0.78M0.62M
Depreciation & Amortization (CF) (Quarter)
1.01M1.01M0.97M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M0.36M
Change in Working Capital
Change in Receivables (Quarter)
0.53M-0.40M-0.13M0.02M-0.05M0.07M-0.02M-0.21M0.13M-0.21M
Change in Account Payables (Quarter)
-0.64M2.43M-1.22M-3.39M4.63M1.97M1.40M2.80M-1.22M-5.37M0.10M3.21M-4.30M
Change in Accured Expenses (Quarter)
4.82M7.92M3.05M6.49M17.89M-16.67M5.59M-1.51M-19.52M5.84M0.46M15.96M1.14M-7.29M-0.31M-1.07M0.47M-0.61M3.67M20.52M
Investing Activities
Capital Expenditures (Quarter)
-1.04M3.44M2.79M1.86M2.10M2.32M1.92M1.50M0.59M0.12M1.78M0.01M0.23M0.38M0.03M-0.00M0.00M
Acquisitions (Quarter)
0.08M0.08M
Change in Acquisitions & Divestments (Quarter)
30.00M35.25M18.10M69.50M85.11M183.02M175.04M118.94M156.71M196.61M203.09M165.19M139.20M104.07M64.82M84.10M97.80M69.46M83.80M118.30M
Cash from Investing Activities (Quarter)
20.79M-292.75M-112.38M43.39M27.19M-146.94M75.31M51.28M71.36M59.68M10.53M45.55M-126.16M29.00M42.47M75.15M39.73M35.46M32.90M-353.03M
Financing Activities
Other financing activities (Quarter)
0.55M
Change in Capital Stock
Shares Issued (Quarter)
1.81M1.77M12.39M1.56M9.33M
Net Equity Issued and Repurchased (Quarter)
0.90M0.66M0.88M0.86M284.70M9.40M17.90M218.20M
Misc.
Cash from Financing Activities (Quarter)
0.90M384.01M0.88M2.00M285.87M1.17M1.30M2.08M9.46M21.92M48.92M1.54M218.89M0.80M0.02M0.93M138.78M323.74M
Change in Cash (Quarter)
-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M20.54M-22.38M-8.47M120.57M-83.40M
Free Cash Flow (Quarter)
-52.16M-43.15M-51.97M-58.95M-68.24M-59.40M-69.05M-70.10M-75.99M-89.31M-52.10M-65.84M-75.31M-57.87M-73.59M-55.29M-62.12M-44.87M-51.11M-54.11M
Net Cash Flow (Quarter)
-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M19.89M-22.38M-8.47M120.57M-83.40M